Rare Or Less Common Cancer Essay

According to statistics published by the American Cancer Society, there will be an estimated 1.5 million new cancer cases diagnosed each year over the next decade. What factors contribute to the yearly incidence

For many types of cancers, we have been using the same base drug (first line treatment) for ten years or even longer. As companies find new drugs to fight the cancers, they hope that it will be the miracle drug that will eradicate the cancer, but it usually isn’t. When they reach this conclusion, instead of returning to the chalkboard and continuing to work to improve the drug, they put the drug on the market as is, and hope it will achieve something. Not only are they putting these drugs on the market but they put price tags on them that would bankrupt anyone without some sort of third party payer. The combination of all of these drugs make up what doctors

Cancer is figured to be the second leading causes of morbidity and mortality worldwide. With approximately 14 million new cases and 8.2 million cancer related deaths in 2012, alone .Why are so many people stuck suffering with this deadly disease? Millions of dollars have been invested into cancer research, yet there is no cure. Are these pharmaceutical companies focus on finding a cure for cancer or concentrating on elongated treatments in order to lengthen their pockets? We must first understand that cancer is big business earning huge profits. Nonetheless, the cancer industry is spending virtually zilch of its multi-billion dollar resources on effective prevention strategies, like dietary guidelines, exercise, natural remedies and herbs proven to cure cancer. Instead, it pours its money into treating cancer, not preventing or allaying it.

Cancer is a major killer of people all around the globe. We do not have a

Breast cancer isn’t a death sentence as it was before. Women used to fear being diagnosed with this disease because there was no cure for it. Breast cancer has been around for centuries, but the advancement of medicine has increased the chances of survival, and in the future the improvements will be even greater.

Different countries will have different survival rates because of the lack of resources, technology, knowledge, and scientists. Cancer is a very tough disease, because there is so much left to learn about it. I do think that with time, cancer will be defeated in our world. By using research, like the one presented by Charlotte Maxeke Johannesburg Academic Hospital, scientist can find factors of cancer and consider treatments to help find causes. They can also help higher survival rates by testing each type of

Incidence data were obtained from population-based cancer registries, which may cover entire national populations but more often covered small

The illness of cancer is no more than big business and a way to create a consistent and large cash flow to those behind the chemical and pharmaceutical industries around the world. The accepted protocol of treating cancer presently does not rid the victim of the disease, but instead weakens them to the point where they cannot recover due to the weakening of their natural internal healing systems. Furthermore, a number of patents that are told they have a cancer in fact do not have cancer at all. This is the unconscionable activity happening to countless people who seek help for ailments, but are lied to and told they have cancer when they don't.

Given that these statistics are for one province, the rates are staggering. Luckily with technology and knowledge increasing at an exponential rate, Canadian Cancer Statistics (2016) demonstrates that although Cancer mortality rates are not declining, trends are showing that people are living longer after being diagnosed with certain cancers. Figure 2 demonstrates the relationship between net survival percentage and survival duration in years. Taking a closer look at the diagram, prostate cancer has a high net percentage survival rate up to ten years therefore men diagnosed with prostate cancer show high survival rates up to ten years post diagnosis. Unfortunately, that is not the case for all types of cancer, as cancer of the lung and bronchus shows a drastic drop between 1 and 3 years of the net survival percentage. In other words, survival rates of lung and bronchus cancer are slim up to and after 1 year post diagnosis and continue to decrease up to 10 years post diagnosis with only 13% survival

Cancer is a disease that is hard to define in one aspect because how it is defined is ever changing due to new unravelings every day, and each individual 's interpretation. Public awareness and misinterpretations make it even harder to define the disease, yet the public is the most fundamental aspect needed to spread knowledge of the impending epidemic and fund it’s defeat. Researchers have been attempting to overcome public speculation and funding obstacles many. To do so, these laborers must redefine cancer, attempt to provide interaction in treatment, continue research such as immunotherapy, duel with grants, work around different regional aspects, and the understand the impact that cancer research could have on other work fields.

RCC contributes for 2-3% of all cancers, producing an age-standardized incidence rate of 6.2 cases/100,000 Australians in 1982, which has increased to 12 cases/100,000 Australians in 2013, highlighted in fig. 1 (Cancer Australia, 2017). In addition, over the past two decades, the global incidence of RCC has increased by over 2% per year, with cancer-specific mortality rates of 30–40%, compared to 20% mortality rates for bladder and prostate cancers. Not only among the Australian population, but the substantial global increase in incidence rates of RCC can be attributed to increased detection following cross-sectional imaging, abdominal ultrasound (US), computed tomography (CT) or MRI during other medical conditions. This is subsequently led to an increased appearance of small renal masses (SRMs), defined as contrast-enhancing masses with a dimension of ≤ 4cm (Ljungberg, 2015). Whilst

Americans paying for cancer treatments are not the only ones worried about the rising costs because, oncologists are also very concerned themselves. There is still much debate about the cost of cancers; pharmacies focus on the cost of drug development

The Cancer Research Society’s (CRS) purpose is to collect funds for cancer research on all kinds of cancer. The association commenced in the year 1945, and it is known to be the first Canadian organization that focuses on gathering finances for cancer research. The institution assists Canadian health care professionals, and researchers to further understand the causation of cancer. Additionally, the institute takes part in the advancement of successful treatments, which could perhaps improve the patient’s life and aid in preventing cancer. The organization contributes to the progression of science, which particularly focuses on preventing, detecting, and treating cancer. The CRS is determined as they have been working on defeating cancer since

Because of the great variance in malignant neoplasms (the cause of cancer), research has not been great enough to save the

Moreover, Australian death rates from breast cancer have been rapidly decreasing since the 1980s when drug therapy trials began, in 1983 the rate was at 38% and in 2012 it had completely halved dropping to 19% which shows the effectiveness of the treatment available and how it has improved over the past thirty years (Wilcken, 2017).